Search

everythinglearnresearchcommunity

for

Search:↓

Clouston syndrome is inherited in an autosomal dominant pattern and caused by a specific gene mutation, with no current treatment available.

High levels of ornithine decarboxylase can cause tumors in mouse skin.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Celiac disease requires more than just a gluten-free diet for effective management.

Pygopus 2 helps ovarian cancer cells grow by aiding ribosomal RNA production, independent of Wnt signaling.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.

MPA increases cancer spread by boosting Eph A2 activity.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Type II keratins are uniquely phosphorylated during stress and mitosis, affecting their structure and function.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Stem cells can move to brain injury sites and be tracked, showing promise for treating brain diseases.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

PIKFyve is essential for normal platelet function and its deficiency causes organ issues and macrophage infiltration.

Endothelin-1 helps amelanotic melanocytes stick and move better on certain proteins.

The LTF gene may help predict and manage nonspecific orbital inflammation.

TGF-beta 1 and IGF-II mRNA have specific patterns in pig subcutaneous tissue, affecting fat and muscle development.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.